Across its top 20 institutional holders, THC's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 5/100, avg. turnover score 28/100).

Quarterly Activity

Recent Activity

+$9.9B

Total Buy Value

$6.4B

Total Sell Value

New buy90

Trim274

Add231

Sold out100

321

Net Buyers

374

Net Sellers

Smart Money Convergence

THC does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/THC

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-23

2026-07-23

Tenet Healthcare Corporation (THC) filed an 8-K on July 23, 2026, announcing its financial results for the quarter ended June 30, 2026. The press release detailing the earnings is attached as Exhibit 99.1. No specific numbers are included in this filing, but the full results are provided in the exhibit.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

88033G407

FAQ

Who are the top institutional investors holding TENET HEALTHCARE CORP (THC)?

Major stakeholders currently include BlackRock, Inc. ($1.6B), FMR LLC ($1.5B), Price T Rowe Associates INC /md/ ($1.4B). Based on the latest 13F filings, there are a total of 693 tracked investment funds and institutions maintaining positions in THC.

What is the overall institutional sentiment toward THC recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $902.7M, driven by 321 managers accumulating shares while 374 reduced their exposure.

Which institutions have been selling or reducing their THC positions?

In the latest period, 274 funds trimmed their holdings, and 100 managers completely exited their positions. The aggregate reported sell value was $6.4B.

Are there any notable investors adding THC to their portfolios?

Yes, buying activity remains notable. 90 institutions opened new positions in {ticker}, and 231 existing holders added to their shares. The total reported buy value for the quarter amounted to $9.9B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,604

Total reported value

$438.9B

629 institutions currently hold both THC and this stock

View detail

LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

644 institutions currently hold both THC and this stock

View detail

ABBV

Abbvie INC

Institutions Holding

4,025

Total reported value

$283.9B

614 institutions currently hold both THC and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access THC's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/THC

CLI

npx alphasmo stocks get THC

Full API & MCP documentation →